Table 6.
Follow-up measurements within 1 year
| Unmatched cohort |
PSM cohort |
|||||
|---|---|---|---|---|---|---|
| HL (N = 1,459) | TFL (N = 470) | P | HL (N = 247) | TFL (N = 247) | P | |
| IPSS, mean (SD) | 5.53 (2.74) | 5.33 (3.13) | 0.252 | 6.06 (2.90) | 5.79 (3.38) | 0.346 |
| IPSS, median [IQR] | 5.00 [0, 21.0] | 5.00 [0, 24.0] | 6.00 [0, 21.0] | 6.00 [0, 24.0] | ||
| QoL, mean (SD) | 1.36 (0.879) | 1.15 (0.849) | <0.001 | 1.38 (0.859) | 1.07 (0.806) | <0.001 |
| QoL, median [IQR] | 1.00 [0, 6.00] | 1.00 [0, 4.00] | 1.00 [0, 5.00] | 1.00 [0, 4.00] | ||
| Qmax, mean (SD) | 20.6 (11.4) | 21.1 (9.63) | 0.378 | 22.5 (8.06) | 20.4 (9.51) | 0.009 |
| Qmax, median [IQR] | 21.0 [0, 64.0] | 23.5 [1.00, 35.0] | 22.0 [0, 56.0] | 21.6 [1.00, 35.0] | ||
| PVR, mean (SD) | 31.3 (32.6) | 15.2 (26.5) | <0.001 | 30.5 (28.4) | 15.3 (32.1) | <0.001 |
| PVR, median [IQR] | 26.0 [0, 444] | 0 [0, 434] | 26.0 [0, 180] | 0 [0, 434] | ||
Data are derived from follow-up visits within 1 year of surgery, i.e., at follow-up times of 1, 3, 6, or 12 months depending on institutional protocol.
HL, holmium laser; IPSS, International Prostate Symptom Score; PSM; propensity score matched; PVR, post-void residual urine volume; Qmax, peak flow rate; QoL, Quality of Life score; SD, standard deviation; TFL, thulium fiber laser.